StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · HKPD·Healthcare

Cellyan Biotechnology Co., Ltd Stock Analysis & AI Score

Cellyan Biotechnology Co., Ltd (HKPD) has an ST Score of 32.2 (C-), driven by its Valuation (B+) and held back by its Growth (F). HKPD last traded at $0.12.

Market Closed
$0.12
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
32
ST Score
32.2/100C-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Distribution
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HKPD
32.2out of 100
Grade C-

Cellyan Biotechnology Co., Ltd (HKPD) has an ST Score of 32.2 (C-), driven by its Valuation (B+) and held back by its Growth (F). HKPD last traded at $0.12.

Strongest
ValuationB+
Weakest
GrowthF
All factor grades
  • ValuationB+
  • Financial StrengthB
  • ProfitabilityD
  • MomentumF
  • GrowthF
  • Piotroski4/9
Score methodology
Press Releases

Contact

HKPD stock: frequently asked questions

What is HKPD's ST Score?

Cellyan Biotechnology Co., Ltd (HKPD) has an ST Score of 32.2 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HKPD a buy, hold, or sell?

Our ST Score grades it C- (32.2/100). The ST Score is a data-driven signal, not a recommendation.

What are HKPD's factor grades?

Valuation B+, Profitability D, Financial Strength B, Momentum F, Growth F.

What is HKPD's valuation grade?

Cellyan Biotechnology Co., Ltd (HKPD) earns a valuation grade of B+, measured against Medical - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HKPD's growth grade?

Cellyan Biotechnology Co., Ltd (HKPD) earns a growth grade of F, measured against Medical - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HKPD's profitability grade?

Cellyan Biotechnology Co., Ltd (HKPD) earns a profitability grade of D, measured against Medical - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HKPD's financial strength grade?

Cellyan Biotechnology Co., Ltd (HKPD) earns a financial strength grade of B, measured against Medical - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is HKPD's Piotroski score?

Cellyan Biotechnology Co., Ltd (HKPD) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.